FDA approves Botox to treat chronic migranes
Friday, October 15, 2010 - 21:10
in Health & Medicine
NEW YORK (Reuters) - The Food and Drug Administration on Friday approved Allergan Inc's anti-wrinkle injection Botox to treat chronic migraines.